Small trial tests creatine for post-HIIT thinking
A newly registered ClinicalTrials.gov study is testing whether seven days of creatine monohydrate can affect cognitive performance after high-intensity interval training in active young men. The trial is notable because it compares two short-term creatine doses, but at this stage the registry entry describes the study design, not the results.
Source: ClinicalTrials.gov
Key Takeaways
- This ClinicalTrials.gov entry describes a 20-participant trial, not published outcome data.
- Researchers are testing whether 7 days of creatine changes reaction time and Trail Making performance after HIIT.
- The study includes two creatine doses: 0.1 g/kg/day and 0.3 g/kg/day, plus placebo groups.
- Because the sample is small and limited to active young men, any eventual findings would need cautious interpretation.
- For readers, the practical takeaway is unchanged: creatine monohydrate remains the best-studied form for performance, while cognition questions are still developing.
What this new creatine trial is actually testing
The news here is not a proven result, but a specific new research question: can a 7-day creatine monohydrate protocol influence cognitive function after high-intensity interval training in active young men?
According to the ClinicalTrials.gov record, the study enrolled 20 participants and measured cognition before and after the intervention using visual reaction time, go/no-go visual reaction time, and Trail Making Tests A and B. Those tests matter because they probe slightly different mental skills: simple response speed, inhibitory control, and aspects of processing speed and executive function.
That makes the trial interesting for creatine users because it is aimed at a real-world question many athletes and gym-goers care about: whether hard training temporarily changes mental sharpness, and whether creatine might help preserve or restore it. This is a different question from creatine’s better-established role in strength, power, and lean mass support.
It also stands out because the design includes two creatine doses rather than just one. In practical terms, that could help researchers see whether a relatively modest short-term dose and a larger loading-style dose behave differently over a single week.
For readers looking for an immediate verdict, the key point is simple: the registry entry does not report the study’s findings. It tells us what was tested, in whom, and how. Until full results are released, any claim that creatine did or did not improve post-HIIT cognition would go beyond the source.
How the study was designed
The trial assigned 20 active young men to one of four groups:
- Placebo plus exercise
- Placebo without exercise
- Creatine 0.1 g/kg body weight per day plus exercise
- Creatine 0.3 g/kg body weight per day plus exercise
That setup allows several comparisons. First, it can compare creatine versus placebo after HIIT. Second, it can compare a lower and higher creatine dose. Third, the non-exercise placebo arm provides a reference point for the effect of the workout itself on the cognitive tests.
One useful detail is that the intervention lasted 7 days. That is long enough to study short-term supplementation and broadly overlaps with common loading approaches used in sports nutrition, though the registry wording does not itself say that the higher dose was intended as a standard loading protocol. In mainstream practice, creatine monohydrate is often taken as about 20 g/day split into 4 doses for 5-7 days, followed by 3-5 g/day as maintenance, as summarised in the ISSN position stand.
Because the dose here is expressed relative to body weight, the actual gram amount would vary by participant. Readers who prefer body-weight-based planning can use a creatine dosage calculator to understand what those doses look like in practice, although this study should not be taken as a dosing recommendation on its own.
In short, the design is thoughtful for a small exploratory trial, but it remains preliminary until results are published.
Why post-HIIT cognition is a meaningful creatine question

Many people think of creatine purely as a muscle supplement, but researchers have increasingly looked at whether it may also affect the brain under demanding conditions. The rationale is straightforward: intense exercise can create fatigue, and some forms of mental performance may dip when the body is stressed. If creatine helps cellular energy availability, it is reasonable to ask whether that could matter for reaction time or executive function after hard intervals.
That does not mean creatine is already proven to sharpen thinking after every workout. The broader evidence on cognition is more mixed and context-dependent than the evidence for strength and power. Effects, when seen, may depend on factors such as sleep loss, mental stress, training load, age, diet, or the exact test being used.
This is why the study’s choice of outcomes matters. Visual reaction time and go/no-go tasks relate to quick decision-making and response inhibition. Trail Making Tests A and B add a more established neuropsychological lens, especially around attention shifting and processing speed. Together, they are more informative than a single simple reaction test alone.
For athletes, coaches, and regular gym users, that makes the trial practically relevant even before results arrive. If a supplement could support not just physical output but also decision-making or attentional control after punishing intervals, that would be useful in sports and training settings. But until the data are published, this remains a plausible hypothesis under investigation, not established practice.
For background on what creatine is already known to do well, our creatine guides and best creatine rankings focus on the much stronger evidence base around monohydrate and exercise performance.
The biggest limitation: there are no posted results yet
The most important limitation is also the easiest to miss: this source is a trial registry entry, not a peer-reviewed paper with outcome data. That means there are no reported effect sizes, no p-values, no confidence intervals, and no details on whether any group improved more than another.
Several other constraints matter too:
- Very small sample: with 20 participants split across four groups, each group is likely tiny, which limits statistical power and increases the chance that findings could be unstable.
- Narrow population: the trial involves active young men, so it would not automatically generalise to women, older adults, sedentary people, or clinical populations.
- Short duration: seven days is useful for acute supplementation questions, but it cannot tell us much about longer-term cognitive effects.
- Specific exercise context: results after HIIT may not apply to resistance training, endurance sessions, or rest days.
These caveats are why responsible reporting has to be careful here. We cannot say creatine improved cognition, harmed cognition, or had no effect. We also cannot identify the better of the two tested doses. All we can accurately say is that researchers designed a small trial to test those possibilities.
That may sound cautious, but it is exactly the right standard. Registry entries are valuable because they show what is being studied. They are not the same thing as conclusive evidence. If full results are released later, the interpretation may change substantially depending on the data quality and magnitude of any effects.
What this means in practice if you take creatine
For now, the practical message for creatine users is modest: this study does not change current best practice. If you are already taking creatine for training performance, recovery support, or muscle-related goals, the most evidence-based choice remains creatine monohydrate.
Mainstream guidance still centres on two common approaches:
- Loading: about 20 g/day split into 4 doses for 5-7 days
- Maintenance: about 3-5 g/day thereafter
Those intake patterns are well established in sports nutrition literature and are discussed in Antonio et al. (2021). This new trial is interesting because one of its tested doses, 0.3 g/kg/day, sits in the neighbourhood of a body-weight-adjusted loading strategy. But that does not mean everyone should start taking creatine specifically to improve post-workout cognition.
If your main goal is proven training benefit, focus on consistency, product quality, and the form with the deepest evidence base. Our creatine brand reviews and creatine product catalog can help you compare straightforward monohydrate options.
If your main interest is mental performance, keep expectations measured. Creatine’s cognitive research is promising in some scenarios, but it is nowhere near as settled as its physical performance data. This study may add a useful piece to that puzzle later, especially because it tests cognition after a demanding training bout, but today it should be viewed as signal-seeking research, not a reason to overhaul your supplement plan.
How this trial fits the broader creatine evidence
In the bigger picture, this study sits at the edge of a much larger and stronger body of work showing that creatine monohydrate is effective for certain exercise-related outcomes. The broad consensus summarised by the ISSN position stand is that creatine is one of the most studied and effective supplements for increasing high-intensity exercise capacity and supporting gains in lean mass during training.
Cognition is a different category. There is scientific interest here, but the evidence is less uniform. Some studies and reviews suggest creatine may help under conditions of high demand or reduced energy availability, while others find limited or no meaningful effect depending on the population and task. That is exactly why a targeted experiment like this one is worth doing.
It also reflects a useful trend in modern sports nutrition research: moving beyond the old question of whether creatine “works” in general, and toward narrower questions about when, for whom, and for which outcomes it might help most.
If later results show a benefit, this trial would still need replication because of its small size and restricted sample. If it shows no effect, that would not invalidate creatine’s established uses; it would simply suggest that short-term supplementation may not meaningfully change these particular cognitive measures in this particular setting.
Either way, the study matters because it targets a plausible but not yet settled application of creatine. That is useful science, provided we keep the claim proportional to the evidence.
Bottom line
A newly registered trial is testing whether 7 days of creatine monohydrate can influence cognitive performance after HIIT in active young men. The design is interesting because it compares placebo with two body-weight-based creatine doses and uses multiple cognitive tests.
What it does not give us yet is the answer. There are no posted results in the source material, so any headline claiming creatine improves post-workout brain function would be premature.
For now, the take-home for readers is straightforward:
- Creatine monohydrate remains the best-supported form of creatine.
- This study explores a promising but still uncertain cognitive use case.
- Until full data appear, your supplementation decisions should be based mainly on the stronger evidence for performance and training adaptation.
That may feel less exciting than a flashy claim, but it is more useful. Good sports nutrition reporting should tell you not just what might be true, but what the evidence actually shows today. In this case, today’s evidence shows that researchers are asking a smart question. We will need the results before we know whether the answer is meaningful for creatine users.
Creatine trial at a glance
- 20 Participants — Active young men split across four groups
- 7 days Supplementation period — Short-term creatine intervention
- 0.1 and 0.3 g/kg/day Creatine doses tested — Both creatine arms were paired with exercise
- 3-5 g/day Typical maintenance intake — Mainstream creatine monohydrate guidance
Frequently Asked Questions
Did this study find that creatine improves thinking after HIIT?
No published result is provided in the source. The ClinicalTrials.gov entry describes the study question and design, but it does not report whether creatine improved, worsened, or did not change the cognitive tests after HIIT.
What kind of creatine was used?
The trial used creatine monohydrate. That matters because monohydrate is the most studied form of creatine and remains the evidence-based standard for most sports nutrition uses.
How much creatine did participants take?
Participants in the creatine groups took either 0.1 g/kg/day or 0.3 g/kg/day for 7 days. Because the dose was based on body weight, the exact gram amount would differ from person to person.
Can I use this study to choose my creatine dose?
Not yet, because the study results are not reported. Until outcome data are available, this registry entry should be viewed as a description of an experiment rather than a basis for changing your own dosing strategy.
Who do the findings apply to if results are eventually positive?
At most, they would directly apply to active young men in a short-term HIIT context. Because the sample is small and specific, any future positive result would need replication before being generalised broadly.
Does this change the usual advice on creatine?
No, current practical advice stays the same. Creatine monohydrate remains the best-supported choice, with common use patterns around 3-5 g/day maintenance or a roughly 20 g/day loading phase split across 4 doses for 5-7 days.